In the few years, and especially since the U.S. government passed the 2018 Farm Bill, CBD products have exploded into the global marketplace. Now that any kind of consumer product imaginable has been marketed with CBD additives—including things like sportswear, pillows, toothpaste, and even hand sanitizer—manufacturers are exploring less prominent cannabinoids to isolate and market in consumer products.
In this FREE Harris Bricken webinar our cannabis and hemp attorneys, Daniel Shortt (Seattle, WA), Griffen Thorne (Los Angeles, CA), Nathalie Bougenies (Portland, OR) and Vince Sliwoski (Portland, OR) discuss the latest trends in the developing cannabinoid market, including CBG, CBN, and others. We also examine the approach to regulating hemp, marijuana, and their cannabinoids within state, federal, and international frameworks. Domestically, we look closely at the FDA, to highlight where we think states will go with regulating “new cannabinoids”. And finally, we discuss intellectual property and a host of other commercial contract issues that are critical for cannabinoid product marketers, manufacturers, and sellers.
Need Help With Cannabis Law?